Summary of Cosm Medical's Seed+ Financing Announcement
On June 5, 2025, iGan Partners announced the first close of a Seed+ financing round for Cosm Medical, a company dedicated to enhancing pelvic health through personalized gynecological care. This round was supported by new investor Spring Impact Capital and several angel investors, and it aims to facilitate Cosm’s expansion in the U.S., clinical validation, and commercial growth.
Cosm Medical’s flagship product, Gynethotics™, utilizes a combination of medical imaging, AI-driven design software, and 3D printing to develop custom vaginal devices, starting with pessaries. This innovative approach addresses common but often neglected health issues related to pelvic floor disorders, which affect nearly half of women over their lifetimes.
Sam Ifergan, a Founding Partner at iGan Partners, emphasized the significance of Cosm’s work in a historically overlooked area of women’s health. He affirmed the firm's commitment to improving outcomes and overall quality of life for millions of women.
Derek Sham, Founder and CEO of Cosm Medical, articulated the company’s vision of redefining women’s health. He highlighted that Gynethotics™ represents not just a technological advancement but also a dedication to personalized care and dignity for patients. With backing from iGan Partners and other investors, Cosm is poised to revolutionize the approach to care for women, ensuring that every solution is customized and impactful.
Olivia Hornby, Managing Partner at Spring Impact Capital, expressed admiration for Sham’s experience in the medical device industry, as well as Cosm’s strong team, intellectual property, and strategic market approach. As impact investors, they were particularly drawn to Cosm’s mission of offering personalized, data-driven Gynethotics™ solutions to better serve the significant number of women experiencing pelvic floor disorders.
Currently, Gynethotics™ pessaries are approved for sale in both Canada and the U.S., and Cosm Medical is actively pursuing broader market presence across North America. The company is simultaneously working on building its clinical dataset and enhancing its product pipeline to cater to additional applications, including postpartum and post-surgical recovery.
Cosm Medical is pioneering a hybrid hardware and software platform aimed at tailoring the treatment of pelvic floor disorders (PFDs), including incontinence and pelvic organ prolapse. Its first product, Gynethotics™, offers made-to-measure gynecological prosthetics, integrating imaging, AI, and 3D printing to enhance patient comfort and reduce complications. By championing precision medicine and digital innovation, Cosm is redefining care in this underserved sector of women’s health.
iGan Partners is a North American venture capital firm focused on investing in promising leaders in the medical technology and digital health sectors. They aim to partner with founders who provide transformative healthcare solutions, enhance patient outcomes, and address system inefficiencies. iGan offers both capital and strategic support to early-stage medical companies and boasts extensive sector expertise and a robust cross-border network.
For more information, visit Cosm Medical and iGan Partners.
This website uses cookies to save your preferences, and track popular pages. Cookies ensure we do not require visitors to register, login, or share any identity information.
